BRATTON DOUGLAS K 13D and 13G filings for Aquestive Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 11:38 am Sale |
2024-12-31 | 13G | Aquestive Therapeutics, Inc. AQST |
BRATTON DOUGLAS K | 10,077,434 11.100% |
-40,000 (-0.40%) |
Filing |
| 2022-02-11 4:03 pm Sale |
2021-12-31 | 13G | Aquestive Therapeutics, Inc. AQST |
BRATTON DOUGLAS K | 10,117,434 25.200% |
-1,494,320 (-12.87%) |
Filing |
| 2021-02-09 3:19 pm Purchase |
2020-12-31 | 13G | Aquestive Therapeutics, Inc. AQST |
BRATTON DOUGLAS K | 11,611,754 34.500% |
26,700 (+0.23%) |
Filing |